Logo del repository
  1. Home
 
Opzioni

Role, indications and controversies of levodopa administration in chronic stroke patients.

Acler M.
•
MANGANOTTI, PAOLO
2013
  • journal article

Periodico
EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE
Abstract
Stroke leaves many patients disabled even after rehabilitative training, representing a major cause of disability. Several approaches to improve outcomes have been attempted in recent years, with only relative benefit. Emerging evidences show a potential role of pharmacological intervention to enhance motor recovery after stroke. Contrasting evidence are coming from experimental and clinical studies, so far, and pharmacological intervention during rehabilitation represents a major controversial in neurorehabilitation. Dopaminergic stimulation appears as one of the most promising way to improve motor recovery. Subject of this paper will be the ratio underlying the clinical use of levodopa in chronic stroke patients, trying to outline the most convincing evidences about a potential role of this drug in rehabilitative strategies.
WOS
WOS:000322428700013
Archivio
http://hdl.handle.net/1234/2833012
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84881409623
http://www.minervamedica.it/it/riviste/europa-medicophysica/articolo.php?cod=R33Y2013N02A0243
Diritti
metadata only access
Soggetti
  • rehabilitation

  • stroke

  • Neuronal Plasticity

Scopus© citazioni
8
Data di acquisizione
Jun 7, 2022
Vedi dettagli
google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback